The miR23b is predicted to bind SARS-CoV-2 ORF1ab and has high expression in human lungs (41), and it is known to hinder human rhinovirus Human rhinovirus 1B (HRV-1B) infection by decreasing the very low-density lipoprotein receptor (42). This evidence concerns the gene VLDLR and infection.